Exelixis | EXEL - EPS Earnings Per Share


Exelixis reported $0.94 in EPS Earnings Per Share for its fiscal quarter ending in September of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2026 0.94 0.88 0.78 Oct/29
FY2026Q2 Jun/2026 0.91 0.85 0.75 Aug/05
FY2026Q1 Mar/2026 0.87 0.76 0.62 May/05
FY2025Q4 Dec/2025 0.97 0.76 0.55 Feb/10
FY2025Q3 Sep/2025 0.78 0.68 0.47 Nov/04




Eps Change Date
Acadia Pharmaceuticals USD 0.18 0.16 Jun/2026
Agios Pharmaceuticals USD -1.69 0 Jun/2026
Akebia Therapeutics USD -0.04 0.04 Dec/2025
Amgen USD 6.29 1.14 Jun/2026
AstraZeneca USD 2.79 0.16 Sep/2026
Bayer EUR 0.95 1.76 Jun/2026
BioMarin Pharmaceutical USD 1.2 0.44 Jun/2026
Bristol-Myers Squibb USD 1.35 0.69 Sep/2026
Cytokinetics USD -1.5 0.17 Jun/2026
Eisai JPY 64.71 76.24 Jun/2026
Eli Lilly USD 7.48 0.9 Sep/2026
Exelixis USD 0.94 0.03 Sep/2026
Genmab DKK 5.43 4.6 Jun/2026
Glaxosmithkline GBP 0.76 0.14 Sep/2026
Incyte USD -3.6 6.69 Sep/2026
Ionis Pharmaceuticals USD -0.69 0.13 Jun/2026
MacroGenics USD 0.31 0.89 Jun/2026
Merck USD 2.49 2.62 Sep/2026
Moderna USD -1.97 1.43 Jun/2026
Nektar Therapeutics USD -1.78 0.43 Mar/2026
Neurocrine Biosciences USD 2.85 0.91 Jun/2026
Novartis USD 2.46 0.05 Sep/2026
Pfizer USD 0.77 0.02 Jun/2026
Puma Biotechnology USD 0.41 0.5 Sep/2024
Sanofi EUR 0.14 2.02 Jun/2026
Takeda JPY 116.95 45.3 Sep/2026
Ultragenyx Pharmaceutical USD -0.9 0.94 Jun/2026
Xencor USD -0.29 1.42 Jun/2026